Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Medulloblastoma × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Obesity 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Tracheal Diseases 1 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Polycystic Ovary Syndrome 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Overweight 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Motor Activity 1 Mesothelioma 1 Meningioma 1 Medulloblastoma 1 Lymphoma 1 Lung Neoplasms 1

Interventions

Temozolomide 5 Cyclophosphamide 5 Etoposide 4 Radiotherapy 3 lutetium Lu 177 dotatate 2 Vincristine 2 Radiation 2 Cisplatin 2 sodium thiosulfate 1 pegfilgrastim 1 olaparib 1 ibrutinib 1 fludarabine 1 fenofibric acid 1 etoposide phosphate 1 Topotecan 1 Thalidomide 1 Tablets 1 Standard of Care 1 Specimen Handling 1 Platinum 1 ONC206 1 Methotrexate 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Lomustine 1 Irinotecan 1 Hearing 1 Filgrastim 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡